Asthma, allergy and vitamin E: Current and future perspectives

Asthma and allergic disease result from interactions of environmental exposures and genetics. Vitamin E is one environmental factor that can modify development of allergy early in life and modify responses to allergen after allergen sensitization. Seemingly varied outcomes from vitamin E are consistent with the differential functions of the isoforms of vitamin E. Mechanistic studies demonstrate that the vitamin E isoforms alpha-tocopherol and gamma-tocopherol have opposite functions in regulation of allergic inflammation and development of allergic disease, with alpha-tocopherol having anti-inflammatory functions and gamma-tocopherol having pro-inflammatory functions in allergy and asthma. Moreover, global differences in prevalence of asthma by country may be a result, at least in part, of differences in consumption of these two isoforms of tocopherols. It is critical in clinical and animal studies that measurements of the isoforms of tocopherols be determined in vehicles for the treatments, and in the plasma and/or tissues before and after intervention. As allergic inflammation is modifiable by tocopheml isoforms, differential regulation by tocopherol isoforms provide a foundation for development of interventions to improve lung function in disease and raise the possibility of early life dietary interventions to limit the development of lung disease.

Automated summary

Asthma and allergic disease are the result of interactions between environmental exposures and genetics. Different isoforms of vitamin E have opposite functions in regulating allergic inflammation and development of allergic disease, which may explain the varying outcomes of vitamin E on allergies.